Ambu A/S (AMBFF)
Ambu A/S operates in the Medical - Devices industry of the Healthcare sector, headquartered in Ballerup, CR, DK. The stock last traded at $10.85, up 0.00% on the session, giving a market capitalisation of $2.85B. On trailing twelve-month figures it carries a trailing P/E of 41.57, a net margin of 7.8%. Its beta of 1.30 implies it has historically moved more than the broad market.
Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S specializes in the global development, manufacturing, and distribution of medical devices. These critical instruments and solutions are supplied to hospitals, clinics, and emergency medical services across the globe. Ambu's comprehensive portfolio addresses key areas of healthcare, including medical visualization, anesthesia, patient monitoring, and diagnostics. Its product lines encompass a wide array of specialized equipment. For endoscopy, offerings include bronchoscopes and associated monitoring systems. In the field of neurology, Ambu provides EEG and EMG electrodes, devices for EMG-guided injections, and intraoperative monitoring tools. Cardiology departments benefit from its range of ECG electrodes. Furthermore, the company delivers an extensive suite of airway management and anesthesia products, such as various bronchoscopes, video laryngoscopes, single and double lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and manual resuscitators. Rounding out its offerings are essential items like extrication collars, CPR breathing barriers, and training manikins.
Ambu A/S is most often compared with the following Healthcare names: